| Reconciliation of Operating Profit (Loss) from Segments to Consolidated |
| | | | | | | | | | | | MedSurg and Neurotechnology | | | | | | | | | | | | | | | | | | MedSurg and Neurotechnology | | | | | | | | | | | | | | | | | | MedSurg and Neurotechnology | | | | | | | | | | | | Segment research, development and engineering expenses | | | | | | MedSurg and Neurotechnology | | | | | | | | | | | | Segment selling, general and administrative expenses | | | | | | MedSurg and Neurotechnology | | | | | | | | | | | | Segment depreciation and amortization | | | | | | | | | | | | Amortization of intangible assets | | | | | | Total depreciation and amortization | | | | | | MedSurg and Neurotechnology | | | | | | | | | | | | | | | | | | Items not allocated to segments: | | | | | | | | | | | | Inventory stepped up to fair value | | | | | | Acquisition and integration-related charges | | | | | | Amortization of intangible assets | | | | | | Structural optimization and other special charges | | | | | | Goodwill and other impairments | | | | | | Medical device regulation | | | | | | | | | | | | Regulatory and legal matters | | | | | | Consolidated operating income | | | | | |
|
| Sales and Other Financial Information by Business Segment |
| | | | | | Segment Assets and Capital Spending | | | | | | | MedSurg and Neurotechnology | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Purchases of property, plant and equipment: | | | | | | | | | | | | MedSurg and Neurotechnology | | | | | | Total segment purchases of property, plant and equipment | | | | | | | | | | | | Total purchases of property, plant and equipment | | | | | |
|
| Geographic Information on Net Sales and Long-Lived Assets |
| | | | | | | | | | | | | | Net Property, Plant and Equipment | | | | | | | | | | | | | | | | | | | | | Europe, Middle East, Africa | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|